Themajority of CD5+ DLBCL cases belong to the activated B-cell subtype ofDLBCL.11,12 Clinically, this molecular subtype of DLBCL follows anaggressive clinical course similar to T-cell lymphomas.13 The gene discussed is CD5; the disease is T-cell non-Hodgkin lymphoma.